English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Our bodies are continuously exposed to a wide range of carcinogens and other DNA-damaging agents, together with endogenous forms of DNA damage, resulting in mutations and complex chromosomal aberrations that can affect oncogenes or tumour suppressor genes. These errors, which can be inherited by daughter cells if they are not resolved, can contribute to malignant transformation (1). In tumours, the gradual acquisition of genetic aberrations can also contribute to the development of drug resistance. Various mechanisms that mediate the repair of DNA lesions are critical in suppressing genome instability, thus elucidating these processes is crucial to our understanding of tumour biology and cancer evolution.

An emerging regulatory network of NHEJ via DYNLL1-mediated 53BP1 redistribution